Bowel Cancer UK, the charity determined to save lives by promoting early diagnosis and address inequalities in treatment and care, has today released a report calling for the liberalisation of national guidelines for GPs on who can be referred for urgent testing for suspected cancer. Nearly 16,000 men and women die of bowel cancer every year in the UK, making it the second most common cause of cancer death in the UK
30 May, 2014
Food and drink researchers have found a new way to produce sparkling wine using magnetised yeast – a process which reduces the time taken to remove waste yeast from weeks to minutes.
29 May, 2014
As you can see from the subject line, this month’s newsletter from Drug Discovery Today deals with various approaches related to phenotypic screening.
28 May, 2014
Neutron analysis at the Institut Laue-Langevin explains the thickening of cancer pharmaceutical solutions that prevents cheaper, more convenient home- based administration through a syringeThe results are an important first step in increasing the concentrations of pharmaceuticals used to treat cancer, arthritis and multiple sclerosis
28 May, 2014
The Government is moving ahead with plans to amend legislation to attract drug research back to the UK. If the changes go ahead, they will remove risks of patent infringement claims when carrying out clinical and other experimental trials of new drugs, according to Withers & Rogers – one of the UK’s leading firms of patent and trade mark attorneys.
23 May, 2014
Newly launched ‘Technology Platform Access’ programme provides the opportunity to work with a pioneering antibody discovery platform that is the result of a multi-million pound investment in UCB’s immunology research centre of excellence
11 May, 2014
GSK hosted Society for Medicines Research event to address challenges
10 May, 2014
An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique allows scientists to study the life-threatening virus in detail and makes screening potential anti-HIV drugs quicker and more efficient. The technique can also be used to study other diseases.
09 May, 2014
LA JOLLA, CA—May 7, 2014—Scientists at The Scripps Research Institute (TSRI) have engineered a bacterium whose genetic material includes an added pair of DNA “letters,” or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the molecular building blocks are supplied.
08 May, 2014